Clínic Barcelona
Clínic Barcelona
Research
February 23 2021
Beneficial effects and mechanisms of action of a new treatment for portal hypertension and hepatic fibrosis described
A study published in the Journal of Hepatology shows for the first time the efficacy of the drug lanifibranor in portal hypertension and hepatic fibr1